Drug Profile
TS 002
Latest Information Update: 03 Apr 2007
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sleep disorders
Most Recent Events
- 02 Jul 2003 Preclinical trials in Sleep disorders in Japan (unspecified route)